alanylglutamine has been researched along with n-glycylglutamic acid in 2 studies
| Studies (alanylglutamine) | Trials (alanylglutamine) | Recent Studies (post-2010) (alanylglutamine) | Studies (n-glycylglutamic acid) | Trials (n-glycylglutamic acid) | Recent Studies (post-2010) (n-glycylglutamic acid) |
|---|---|---|---|---|---|
| 271 | 73 | 112 | 19 | 1 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adibi, SA | 1 |
| Ollenschläger, G; Roth, E; Simmel, A | 1 |
1 review(s) available for alanylglutamine and n-glycylglutamic acid
| Article | Year |
|---|---|
Intravenous use of glutamine in peptide form: clinical applications of old and new observations.
Topics: Animals; Dipeptides; Glutamine; Humans; Infusions, Intravenous; Parenteral Nutrition, Total | 1989 |
1 other study(ies) available for alanylglutamine and n-glycylglutamic acid
| Article | Year |
|---|---|
Availability of glutamine from peptides and acetylglutamine for human tumor-cell cultures.
Topics: Breast Neoplasms; Cell Division; Dipeptides; DNA; Glutamine; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms; Tumor Cells, Cultured | 1989 |